Scinai Immunotherapeutics Ltd ADR (SCNI)

$0.74 +0.28 (61.62%)
Market Cap 1.61M
Revenue (ttm) 1.31M
Net Income (ttm) -8.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -634.35%
Debt to Equity Ratio 0.04
Volume 200,799,500
Avg Vol 4,066,158
Day's Range N/A - N/A
Shares Out 3.54M
Stochastic %K 47%
Beta 1.98
Analysts Strong Buy
Price Target $8.00

Company Profile

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufac...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 8 930 2529
Fax: 972 8 930 2531
Address:
Jerusalem BioPark, 2nd floor Hadassah Ein Kerem Campus, Jerusalem, Israel
topstockalerts
topstockalerts Apr. 25 at 9:59 PM
Fridays Top Gainers $MXL $SCNI $HUBCW $LINT $INTW
0 · Reply
Maydate8
Maydate8 Apr. 25 at 7:41 PM
Thank you @ApolloAlerts I made me 6k from his calls this month. This guy has been on fire lately, give him a FOLLOW❤️ Also watching: $MXL $SCNI $ATOM
0 · Reply
Bulltrader988
Bulltrader988 Apr. 25 at 7:23 PM
$SCNI 👃👀 https://x.com/i/status/2048049720518647902
0 · Reply
Bulltrader988
Bulltrader988 Apr. 25 at 7:06 PM
$SCNI "...The aggregate gross proceeds from the private placement and the warrant inducement transaction are approximately $2.61 million, before deducting fees and expenses, and the closing of the transactions is expected to occur on or about April 27, 2026, subject to satisfaction of customary closing conditions..." Private Placement transactions should close monday 👃👀
0 · Reply
TeamBullish
TeamBullish Apr. 25 at 6:26 PM
Top setups for next weeks session! $CTNT $SMX $ENVB $ELPW $SCNI https://youtu.be/zwZYVAF4w0o
1 · Reply
RoyalImperial
RoyalImperial Apr. 25 at 5:34 PM
MITQ ✅ Has that look for next week, one of the most undervalued and cleanest micro caps. Latest news + contracts rolling in Low float (6M) NO dilution Record earnings trend 📈. A $9M projector refresh contract plus other large projects shifting into FY2026 means a significant revenue surge is likely already locked in and coming. $SCNI $WTI $OFAL $IHRT on watch ...1
0 · Reply
WickedWins
WickedWins Apr. 25 at 5:01 PM
Continuation for next week, keeping eyes on these below: $MITQ $SMX $CHSN $DKI $SCNI
0 · Reply
Ric_1M
Ric_1M Apr. 25 at 11:31 AM
$MXL $SCNI $ATOM $IHRT $OGN "We may have all come on different ships, but we're in the same boat now." Martin Luther King Jr.
1 · Reply
Longislandbull
Longislandbull Apr. 25 at 6:18 AM
$SCNI wonderful guidance in our discord where we nailed the move @ market open. Come trade with us for free 👇 https://trifectatrading.tiiny.site/
0 · Reply
AngelicGoku
AngelicGoku Apr. 25 at 6:11 AM
$MITQ squeeze starting, low floaters are starting to pickup as well, great timing $ELPW $SCNI
0 · Reply
Latest News on SCNI
Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today

Fri, 24 Apr 2026 10:25:04 -0400 - 1 day ago

Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Fri, 24 Apr 2026 08:00:00 -0400 - 1 day ago

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities

Mon, 06 Apr 2026 07:00:00 -0400 - 19 days ago

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities

Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

Wed, 01 Apr 2026 07:35:00 -0400 - 24 days ago

Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026

Mar 19, 2026, 7:50 AM EDT - 5 weeks ago

Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026

Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price

Mar 16, 2026, 4:05 PM EDT - 5 weeks ago

Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price

Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

Mar 2, 2026, 9:20 AM EST - 7 weeks ago

Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform

Feb 25, 2026, 8:11 AM EST - 2 months ago

Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform

Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm

Feb 17, 2026, 7:00 AM EST - 2 months ago

Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm

Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL

Jan 7, 2026, 7:00 AM EST - 3 months ago

Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL

Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances

Dec 2, 2025, 8:50 AM EST - 5 months ago

Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances

Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities

Oct 6, 2025, 7:30 AM EDT - 7 months ago

Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities

Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet

Sep 2, 2025, 7:30 AM EDT - 8 months ago

Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet

Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN

Jul 29, 2025, 7:15 AM EDT - 9 months ago

Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN

Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025

Jun 12, 2025, 8:00 AM EDT - 11 months ago

Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025

Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.

Jun 5, 2025, 9:00 AM EDT - 11 months ago

Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.

Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn

May 30, 2025, 7:00 AM EDT - 11 months ago

Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn

Scinai Announces Annual Financial Results for 2024

May 7, 2025, 4:01 PM EDT - 1 year ago

Scinai Announces Annual Financial Results for 2024

Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases

May 1, 2025, 7:00 AM EDT - 1 year ago

Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases

Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions

Mar 27, 2025, 9:25 AM EDT - 1 year ago

Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions

Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Mar 5, 2025, 7:30 AM EST - 1 year ago

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Jan 6, 2025, 7:31 AM EST - 1 year ago

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Dec 16, 2024, 9:25 AM EST - 1 year ago

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

Dec 5, 2024, 8:25 AM EST - 1 year ago

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

Nov 27, 2024, 8:00 AM EST - 1 year ago

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

Nov 22, 2024, 7:15 AM EST - 1 year ago

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Oct 31, 2024, 6:59 AM EDT - 1 year ago

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

Sep 16, 2024, 7:00 AM EDT - 1 year ago

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

IBN Announces Latest Episode of The BioMedWire Podcast featuring Amir Reichman, CEO of Scinai Immunotherapeutics Ltd.

Sep 9, 2024, 11:12 AM EDT - 1 year ago

IBN Announces Latest Episode of The BioMedWire Podcast featuring Amir Reichman, CEO of Scinai Immunotherapeutics Ltd.

Scinai Regains Full Compliance with Nasdaq Listing Requirements

Aug 29, 2024, 6:31 AM EDT - 1 year ago

Scinai Regains Full Compliance with Nasdaq Listing Requirements

Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000

Aug 21, 2024, 8:45 AM EDT - 1 year ago

Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000

Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder

Aug 20, 2024, 9:30 AM EDT - 1 year ago

Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder

Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23

Aug 15, 2024, 7:00 AM EDT - 1 year ago

Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23

Scinai Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting Approximately $29 million of Debt to Preferred Equity Convertible into 19.5% Common Equity

Aug 13, 2024, 7:00 AM EDT - 1 year ago

Scinai Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting Approximately $29 million of Debt to Preferred Equity Convertible into 19.5% Common Equity

Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb

Scinai Immunotherapeutics stock surges 55% on breakthrough psoriasis treatment results

Jul 15, 2024, 12:31 PM EDT - 1 year ago

Scinai Immunotherapeutics stock surges 55% on breakthrough psoriasis treatment results

Scinai Immunotherapeutics Announces promising results in an in-vivo proof-of-concept psoriatic human skin model

Jul 15, 2024, 7:00 AM EDT - 1 year ago

Scinai Immunotherapeutics Announces promising results in an in-vivo proof-of-concept psoriatic human skin model

Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity

Jul 8, 2024, 8:14 AM EDT - 1 year ago

Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity

Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Jul 3, 2024, 9:32 AM EDT - 1 year ago

Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Scinai Publishes Q1 2024 Financial Results and Provides Business Update

Jul 2, 2024, 8:12 AM EDT - 1 year ago

Scinai Publishes Q1 2024 Financial Results and Provides Business Update

Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.

Jun 13, 2024, 7:00 AM EDT - 2 years ago

Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.

Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement

Jun 7, 2024, 7:00 AM EDT - 2 years ago

Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement

Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance

May 24, 2024, 4:01 PM EDT - 2 years ago

Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance

Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update

May 15, 2024, 4:01 PM EDT - 2 years ago

Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

May 6, 2024, 9:21 AM EDT - 2 years ago

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

Apr 10, 2024, 7:00 AM EDT - 2 years ago

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Apr 8, 2024, 7:00 AM EDT - 2 years ago

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Scinai leadership to attend BIO-Europe Spring 2024

Mar 12, 2024, 8:00 AM EDT - 2 years ago

Scinai leadership to attend BIO-Europe Spring 2024

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

Feb 29, 2024, 8:45 AM EST - 2 years ago

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

topstockalerts
topstockalerts Apr. 25 at 9:59 PM
Fridays Top Gainers $MXL $SCNI $HUBCW $LINT $INTW
0 · Reply
Maydate8
Maydate8 Apr. 25 at 7:41 PM
Thank you @ApolloAlerts I made me 6k from his calls this month. This guy has been on fire lately, give him a FOLLOW❤️ Also watching: $MXL $SCNI $ATOM
0 · Reply
Bulltrader988
Bulltrader988 Apr. 25 at 7:23 PM
$SCNI 👃👀 https://x.com/i/status/2048049720518647902
0 · Reply
Bulltrader988
Bulltrader988 Apr. 25 at 7:06 PM
$SCNI "...The aggregate gross proceeds from the private placement and the warrant inducement transaction are approximately $2.61 million, before deducting fees and expenses, and the closing of the transactions is expected to occur on or about April 27, 2026, subject to satisfaction of customary closing conditions..." Private Placement transactions should close monday 👃👀
0 · Reply
TeamBullish
TeamBullish Apr. 25 at 6:26 PM
Top setups for next weeks session! $CTNT $SMX $ENVB $ELPW $SCNI https://youtu.be/zwZYVAF4w0o
1 · Reply
RoyalImperial
RoyalImperial Apr. 25 at 5:34 PM
MITQ ✅ Has that look for next week, one of the most undervalued and cleanest micro caps. Latest news + contracts rolling in Low float (6M) NO dilution Record earnings trend 📈. A $9M projector refresh contract plus other large projects shifting into FY2026 means a significant revenue surge is likely already locked in and coming. $SCNI $WTI $OFAL $IHRT on watch ...1
0 · Reply
WickedWins
WickedWins Apr. 25 at 5:01 PM
Continuation for next week, keeping eyes on these below: $MITQ $SMX $CHSN $DKI $SCNI
0 · Reply
Ric_1M
Ric_1M Apr. 25 at 11:31 AM
$MXL $SCNI $ATOM $IHRT $OGN "We may have all come on different ships, but we're in the same boat now." Martin Luther King Jr.
1 · Reply
Longislandbull
Longislandbull Apr. 25 at 6:18 AM
$SCNI wonderful guidance in our discord where we nailed the move @ market open. Come trade with us for free 👇 https://trifectatrading.tiiny.site/
0 · Reply
AngelicGoku
AngelicGoku Apr. 25 at 6:11 AM
$MITQ squeeze starting, low floaters are starting to pickup as well, great timing $ELPW $SCNI
0 · Reply
ZephyrsDrift
ZephyrsDrift Apr. 25 at 12:28 AM
$MITQ Bottom reversal. Low risk play here, no dilution, plenty of cash on hand and a small float. Watch for volume next week. Profitable week we had on $SCNI $ELPW $RPGL and $LIDR just to name a few.
0 · Reply
WickedWins
WickedWins Apr. 25 at 12:10 AM
Continuation for next week, keeping eyes on these: $MITQ $SMX $CHSN $DKI $SCNI
1 · Reply
topstockalerts
topstockalerts Apr. 24 at 11:27 PM
Top Gainers $MXL $SCNI $HUBCW $XE $INTW
0 · Reply
ProfessorDman1
ProfessorDman1 Apr. 24 at 11:16 PM
$OBAI this should be next .40-.50 cents stock to run after $GMEX $DKI $SCNI
0 · Reply
secondz2late
secondz2late Apr. 24 at 11:16 PM
$SCNI held up so well all day to just completely crumble after hours
0 · Reply
topstockalerts
topstockalerts Apr. 24 at 10:59 PM
$SCNI this is the type that leaves people waiting on the sidelines
0 · Reply
Godwins26
Godwins26 Apr. 24 at 10:55 PM
Thanks for the cheap price time to run this up 😊 $CTNT $SCNI $AKAN $ATOM $OGN
0 · Reply
secondz2late
secondz2late Apr. 24 at 9:58 PM
$SCNI 200 million volume suckered me into this failure
0 · Reply
Lookingforyourass
Lookingforyourass Apr. 24 at 9:45 PM
$SCNI what a shit stock
0 · Reply
RoyalImperial
RoyalImperial Apr. 24 at 9:20 PM
MITQ looking ready, keep eyes on this one. Latest news + contracts rolling in Low float (~sub 10M) NO dilution Record earnings trend 📈 $SCNI $HRTX $CREG $RPGL .,
0 · Reply
Dumbull77
Dumbull77 Apr. 24 at 9:09 PM
$SCNI Only 3.5 million shares out my 🫏
0 · Reply
TeamBullish
TeamBullish Apr. 24 at 9:01 PM
Kept it conservative this week, protected capital, and that’s exactly what matters in this cycle. We’ll be ready to roll into next week once momentum shifts and gainers start producing cleaner returns. Hope you all had a solid week, enjoy your weekend! $SKLZ $CTNT $SCNI $GMEX $ELPW
2 · Reply